antihemophilic factor (recombinant), glycopegylated-exei

FDA Drug Profile — ESPEROCT

antihemophilic factor (recombinant), glycopegylated-exei is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including ESPEROCT. Available dosage form: kit.

Drug Details

Generic Name
antihemophilic factor (recombinant), glycopegylated-exei
Brand Names
ESPEROCT
Application Number
BLA125671
Sponsor
Novo Nordisk
NDC Codes
7
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A